Coherex Medical Announces Breakfast Symposium and Executive Presentations during
This Week’s TCT 2008 (the Transcatheter Cardiovascular Techniques Conference)

SALT LAKE CITY and WASHINGTON, D.C. – October 12, 2007 – Coherex Medical, Inc., a privately held medical device company, today announced its TCT 2008 schedule of events and highlighted two presentations its executives will deliver during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium held in Washington, D.C. October 12-17, 2008 and produced by the Cardiovascular Research Foundation (CRF).

Coherex is sponsoring a breakfast symposium during TCT 2008 entitled “The Science of Headache: A New Collaboration Between Neurology and Cardiology.” This symposium will be held from 7 to 8 a.m. (EDT) on Tuesday, October 14 in Room 144C in the Walter E. Washington Convention Center in Washington, D.C. TCT participants are welcome to attend the symposium.

In addition, Coherex executives will deliver two presentations during TCT and also participate in follow-up panel discussions.

Specifically, Dr. Brian Whisenant, chairman and founder of Coherex Medical, will deliver a presentation on Monday, October 13 at 4:59 p.m. (EDT) titled “The Coherex ‘Intra-Tunnel’ PFO Closure Device: Early Clinical Experiences (Special Emphasis on Migraine Prevention).” Additionally, Richard J. Linder, president and CEO of Coherex, will deliver a presentation on Wednesday, October 15 at 4:59 p.m. (EDT) titled “Industry Perspectives: The Challenge of Consensus Building.”

Coherex Medical’s Breakfast Symposium Program Details
The specific schedule for the Coherex breakfast symposium program is as follows:

7:00 a.m.     “Coherex Medical: Bringing Science to the Forefront,”
                     Richard J. Linder (Coherex Medical, President & CEO)
7:05 a.m.      “PFO Headache: Evolution of a Connection,”
                     Brian Whisenant, M.D. (Utah Heart Clinic, Salt Lake City
                     and Coherex Medical co-founder)
7:20 a.m.     “Migraine and the Heart: What Every Cardiologist Should Know About
                    PFO and Migraine” Richard B. Lipton, M.D. (Vice Chair of Neurology,
                    Albert Einstein College of Medicine, and Director, Headache Center,
                    Montefiore Medical Center, both Bronx, N.Y.)
7:35 a.m.     “Update: International Experience with the Coherex FlatStent™ PFO
                    Closure System,” Jonathan M. Tobis, M.D. (UCLA Medical Center)
7:45 a.m.     Panel Discussion and Q&A Session
8:00 a.m.     Program Close

About Coherex Medical
Formed in 2003 by Brian Whisenant, M.D., Coherex Medical is focused on addressing structural heart disease and conditions through medical devices. For more information, please visit www.coherex.com or call 801-433-9900.

About the Coherex FlatStent PFO Closure System
The Coherex FlatStent™ PFO Closure System is similar in use and function to self-expanding vascular stents which are widely used by interventional cardiologists. However, the patent-pending Coherex FlatStent Closure System incorporates a unique fusion of PFO closure mechanisms and accepted medical practices in a design expected to naturally seal a PFO tunnel.

# # #

Coherex Medical and Coherex FlatStent are trademarks of Coherex Medical, Inc. All other trademarks are the properties of their respective owners.

Coherex Medical Contacts:
Trent Loveless, Coherex Medical, 801-433-9900, tloveless@coherex.com or
David Politis, Politis Communications, 801-523-3730(w)/801-556-8184(c), dpolitis@politis.com

09/22/09
Coherex Medical Signs Exclusive Distribution Agreement with Abbott

09/22/09
Coherex Medical Announces Lunch Symposium during TCT 2009
(the Transcatheter Cardiovascular Therapeutics Conference) on Tues., Sept. 22, 2009

08/20/09
Coherex Medical Closes $16.5 Million Series B Preferred Stock Financing

07/08/09
Coherex Medical’s Coherex FlatStent EF PFO Closure System Granted CE Mark Clearance for Closing PFOs – a Common Heart Defect; Company to Begin Sales/Marketing Efforts in Europe

07/08/09
CE Mark Clearance for Coherex Medical’s Coherex FlatStent EF PFO Closure System

10/13/08
Chronic Migraines Caused by a Hole in the Heart? “Highly Likely,” New Research Says

10/12/08
Coherex Medical Announces Breakfast Symposium and Executive Presentations During This Week’s TCT 2008 (the Transcatheter Cardiovascular Techniques Conference)

10/21/07
First “Live Case” Transmission of a PFO Closure Procedure Using the Coherex FlatStent PFO Closure System to be Presented at TCT 2007

10/03/07
Coherex Medical Successfully Completes First Human Cases with its Coherex FlatStent PFO Closure System as Company Begins COHEREX-EU Study to Seek CE Mark Clearance

10/03/07
Utah company's new stent may help repair heart defects

10/02/07
Coherex Medical to Begin its COHEREX-EU Study to Pursue CE Mark Clearance for its Coherex FlatStent PFO Closure System

10/01/07
Coherex Medical has been invited to deliver a presentation at In3 East, Boston, one of the leading venture capital and strategic partnership conferences in the United States

05/10/07
2007 Utah Innovation Awards Winners

04/17/07
2007 Utah Innovation Awards Finalists